• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊拉克已鉴定的新冠病毒变异株的基因组多样性与进化

Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq.

作者信息

Al-Mankhee Ahmed A, Moatasim Yassmin, El Taweel Ahmed, Gomaa Mokhtar, Rabiee Omar A, Gado Marwa M, Barakat Ahmed B, Ali Mohamed A, El-Shesheny Rabeh

机构信息

Al Hussein Teaching Hospital, Al Bat'haa 64011, Thi Qar, Iraq.

Department of Microbiology, Faculty of Science, Ain Shams University, Cairo 11566, Egypt.

出版信息

Pathogens. 2024 Nov 29;13(12):1051. doi: 10.3390/pathogens13121051.

DOI:10.3390/pathogens13121051
PMID:39770311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728743/
Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus continues to circulate worldwide, causing the deaths of millions of people. The continuous circulation of the virus, its genetic diversity, the emergence of new variants with increased transmissibility, and/or the capacity of the virus to escape from the immune system constitute a major public health concern. In our study, we aimed to characterize SARS-CoV-2 strains in Iraq from the first introduction until the end of 2023, and to identify their variants, lineages, clades, and mutation patterns. All published Iraqi full genome sequences (2020-2023) were obtained from Global Initiative on Sharing All Influenza Data (GISAID) and subjected to molecular characterization along with 19 samples of full genome sequences that were collected during the fifth and sixth waves of the SARS-CoV-2 pandemic in this study. Next-generation sequencing was performed using an Illumina MiSeq system, and phylogenetic analysis was performed for all the Iraqi sequences. Three established global platforms, GISAID, Nextstrain, and PANGO, were used for the classification of isolates into distinct clades, variants, and lineages. Six wave peaks of COVID-19 cases have been identified in Iraq, resulting in approximately 2,400,000 cumulative confirmed cases and more than 25,000 deaths. Our study revealed patterns of circulation and dominance of SARS-CoV-2 clades and their lineages in the pandemic waves in the country.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型冠状病毒肺炎(COVID-19)大流行仍在全球范围内传播,导致数百万人死亡。病毒的持续传播、其基因多样性、具有更高传播性的新变种的出现和/或病毒逃避免疫系统的能力构成了重大的公共卫生问题。在我们的研究中,我们旨在描述2020年首次引入到2023年底伊拉克的SARS-CoV-2毒株特征,并确定其变种、谱系、进化枝和突变模式。所有已发表的伊拉克全基因组序列(2020 - 2023年)均从全球共享流感数据倡议组织(GISAID)获取,并与本研究中在SARS-CoV-2大流行的第五波和第六波期间收集的19个全基因组序列样本一起进行分子特征分析。使用Illumina MiSeq系统进行下一代测序,并对所有伊拉克序列进行系统发育分析。利用三个成熟的全球平台GISAID、Nextstrain和PANGO将分离株分类为不同的进化枝、变种和谱系。伊拉克已确定出现了六个新型冠状病毒肺炎病例高峰,累计确诊病例约240万例,死亡人数超过2.5万例。我们的研究揭示了该国大流行各波次中SARS-CoV-2进化枝及其谱系的传播模式和优势情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/95febdd308fd/pathogens-13-01051-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/18846eff0a45/pathogens-13-01051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/d22c64cf32af/pathogens-13-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/cd7b567b480e/pathogens-13-01051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/a488558a4708/pathogens-13-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/95febdd308fd/pathogens-13-01051-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/18846eff0a45/pathogens-13-01051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/d22c64cf32af/pathogens-13-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/cd7b567b480e/pathogens-13-01051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/a488558a4708/pathogens-13-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d41b/11728743/95febdd308fd/pathogens-13-01051-g005a.jpg

相似文献

1
Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq.伊拉克已鉴定的新冠病毒变异株的基因组多样性与进化
Pathogens. 2024 Nov 29;13(12):1051. doi: 10.3390/pathogens13121051.
2
Complete Genomic Characterisation and Mutation Patterns of Iraqi SARS-CoV-2 Isolates.伊拉克新冠病毒分离株的全基因组特征及突变模式
Diagnostics (Basel). 2022 Dec 21;13(1):8. doi: 10.3390/diagnostics13010008.
3
Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.印度地区 SARS-CoV-2 全基因组序列的系统发育分类及进化趋势。
Indian J Med Res. 2021;153(1 & 2):166-174. doi: 10.4103/ijmr.IJMR_3418_20.
4
Sequencing and mutations analysis of the first recorded SARS-CoV-2 Omicron variant during the fourth wave of pandemic in Iraq.伊拉克第四波大流行期间首次记录的 SARS-CoV-2 奥密克戎变异株的测序和突变分析。
Braz J Infect Dis. 2022 Sep-Oct;26(5):102677. doi: 10.1016/j.bjid.2022.102677. Epub 2022 Aug 8.
5
Dominance of SARS-CoV-2 Delta AY.33 sublineage and Omicron BA.1.1 sublineage in Erbil City/Kurdistan Region of Iraq.伊拉克库尔德地区埃尔比勒市中 SARS-CoV-2 Delta AY.33 亚系和奥密克戎 BA.1.1 亚系的优势地位。
Cell Mol Biol (Noisy-le-grand). 2024 Nov 24;70(10):83-90. doi: 10.14715/cmb/2024.70.10.12.
6
Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India.印度中部 SARS-CoV-2 谱系的分子特征和基因组监测。
Viruses. 2024 Oct 14;16(10):1608. doi: 10.3390/v16101608.
7
SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region.伊拉克库尔德地区 SARS-CoV-2 奥密克戎变异株的基因组和系统进化分析。
Genes (Basel). 2023 Jan 9;14(1):173. doi: 10.3390/genes14010173.
8
Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.比较 2020-2022 年埃及出现的 SARS-CoV-2 奥密克戎变异株与之前鉴定的 SARS-CoV-2 变异株:对 SARS-CoV-2 基因组进化及其对流行病学、临床特征、疾病严重程度和死亡率影响的深入了解。
BMC Infect Dis. 2023 Aug 18;23(1):542. doi: 10.1186/s12879-023-08527-y.
9
[Genomic Characterization of SARS-CoV-2 Isolates Obtained from Antalya, Türkiye].[从土耳其安塔利亚获得的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)分离株的基因组特征分析]
Mikrobiyol Bul. 2024 Oct;58(4):433-447. doi: 10.5578/mb.20249643.
10
COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.2019冠状病毒病基因组监测:印度中部两年间严重急性呼吸综合征冠状病毒2变体的地理分布及突变图谱
Virus Res. 2024 Jun;344:199365. doi: 10.1016/j.virusres.2024.199365. Epub 2024 Mar 29.

本文引用的文献

1
Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.奥密克戎变异株 BA.1 至 BA.5 的进化:免疫逃逸和传播的影响。
Rev Med Virol. 2022 Sep;32(5):e2381. doi: 10.1002/rmv.2381. Epub 2022 Jul 20.
2
An early warning system for emerging SARS-CoV-2 variants.新型严重急性呼吸综合征冠状病毒 2 变异株早期预警系统。
Nat Med. 2022 Jun;28(6):1110-1115. doi: 10.1038/s41591-022-01836-w.
3
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.
苏格兰关注的奥密克戎变异株的严重程度和疫苗加强针预防有症状疾病的效果(EAVE II):一项具有巢式病例对照研究设计的全国队列研究。
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
4
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.
5
Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.生物技术视角下的 COVID-19 大流行应对策略:精准诊断与不可避免的疫苗范式。
Cells. 2022 Mar 31;11(7):1182. doi: 10.3390/cells11071182.
6
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines.不断演变的 SARS-CoV-2 突变和变体对 COVID-19 疫苗的影响。
mBio. 2022 Apr 26;13(2):e0297921. doi: 10.1128/mbio.02979-21. Epub 2022 Mar 30.
7
Global landscape of SARS-CoV-2 genomic surveillance and data sharing.全球 SARS-CoV-2 基因组监测和数据共享的格局。
Nat Genet. 2022 Apr;54(4):499-507. doi: 10.1038/s41588-022-01033-y. Epub 2022 Mar 28.
8
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.奥密克戎变异株的融合性和致病性减弱。
Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1.
9
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.基于肽的泛冠状病毒融合抑制剂对新冠病毒奥密克戎变异株仍保持高效力。
Cell Res. 2022 Apr;32(4):404-406. doi: 10.1038/s41422-022-00617-x. Epub 2022 Jan 27.
10
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.关注的 SARS-CoV-2 变异株的疾病严重程度和临床结局。
Front Public Health. 2021 Nov 30;9:775224. doi: 10.3389/fpubh.2021.775224. eCollection 2021.